---
title: "12 Health Care Stocks Moving In Thursday's After-Market Session"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/292255634.md"
description: "During Thursday's after-market session, several healthcare stocks experienced significant movements. Gainers included AVITA Medical (+11.1%), Lisata Therapeutics (+10.97%), and MeiraGTx Holdings (+6.81%). Conversely, losers featured Basel Medical Group (-11.6%), Virax Biolabs Group (-10.54%), and Circle8 Group (-8.56%). The report highlights specific percentage changes and market capitalizations for these listed companies."
datetime: "2026-07-09T21:05:37.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/292255634.md)
  - [en](https://longbridge.com/en/news/292255634.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/292255634.md)
generator: "portal-rs"
---

# 12 Health Care Stocks Moving In Thursday's After-Market Session

### Gainers

-   **AVITA Medical** (NASDAQ:RCEL) stock moved upwards by 11.1% to $4.9 during Thursday's after-market session. The market value of their outstanding shares is at $143.1 million.
-   **Lisata Therapeutics** (NASDAQ:LSTA) stock moved upwards by 10.97% to $3.59. The company's market cap stands at $29.2 million.
-   **MeiraGTx Holdings** (NASDAQ:MGTX) shares increased by 6.81% to $14.89. The company's market cap stands at $1.3 billion.
-   **Zhengye Biotechnology** (NASDAQ:ZYBT) stock rose 6.21% to $0.82. The market value of their outstanding shares is at $36.5 million.
-   **aTyr Pharma** (NASDAQ:ATYR) stock increased by 5.98% to $0.62. The market value of their outstanding shares is at $63.0 million.
-   **rYojbaba** (NASDAQ:RYOJ) stock rose 5.41% to $4.09. The company's market cap stands at $33.1 million.

### Losers

-   **Basel Medical Group** (NASDAQ:BMGL) stock declined by 11.6% to $5.88 during Thursday's after-market session. The company's market cap stands at $9.7 million.
-   **Virax Biolabs Group** (NASDAQ:VRAX) stock decreased by 10.54% to $5.69. The market value of their outstanding shares is at $2.5 million.
-   **Circle8 Group** (NASDAQ:CIRC) stock declined by 8.56% to $0.85. The company's market cap stands at $54.2 million.
-   **SciSparc** (NASDAQ:SPRC) shares decreased by 7.16% to $5.06. The market value of their outstanding shares is at $3.1 million.
-   **BGM Group** (NASDAQ:BGM) shares decreased by 6.68% to $0.32. The market value of their outstanding shares is at $125.8 million.
-   **Bone Biologics** (NASDAQ:BBLG) shares decreased by 6.53% to $1.29. The company's market cap stands at $2.4 million. **See Also:** www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

### Related Stocks

- [BMGL.US](https://longbridge.com/en/quote/BMGL.US.md)
- [VRAX.US](https://longbridge.com/en/quote/VRAX.US.md)
- [LSTA.US](https://longbridge.com/en/quote/LSTA.US.md)
- [MGTX.US](https://longbridge.com/en/quote/MGTX.US.md)
- [RCEL.US](https://longbridge.com/en/quote/RCEL.US.md)
- [CIRC.US](https://longbridge.com/en/quote/CIRC.US.md)
- [ZYBT.US](https://longbridge.com/en/quote/ZYBT.US.md)
- [ATYR.US](https://longbridge.com/en/quote/ATYR.US.md)
- [RYOJ.US](https://longbridge.com/en/quote/RYOJ.US.md)
- [SPRC.US](https://longbridge.com/en/quote/SPRC.US.md)
- [BGM.US](https://longbridge.com/en/quote/BGM.US.md)
- [BBLG.US](https://longbridge.com/en/quote/BBLG.US.md)
- [BBLGW.US](https://longbridge.com/en/quote/BBLGW.US.md)

## Related News & Research

- [MeiraGTx (NASDAQ:MGTX) Shares Up 4.3%  - Here's Why](https://longbridge.com/en/news/297689402.md)
- [Virax Biolabs adjourns shareholder meeting after quorum fails to show](https://longbridge.com/en/news/297085985.md)
- [09:01 ETHealthcare Is Moving Into the Home. Home Accessibility Now Has a Validated Score.](https://longbridge.com/en/news/297656740.md)
- [Is Goldman Sachs Stock Outperforming the Nasdaq?](https://longbridge.com/en/news/297672766.md)
- [Morgans Remains a Buy on EchoIQ Limited (EIQ)](https://longbridge.com/en/news/297720502.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**